Biallelic GLB1 mutations are pathogenic for GM1 gangliosidosis, an AR LSD characterised by β-galactosidase deficiency and ganglioside substrate accumulation within lysosomes (Figure 2). The gene discussed is GLB1; the disease is GM1 gangliosidosis.